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Background
Mother to Child HIV-1 Transmission (MTCT) is infre-
quent among women who receive highly active antiretro-
viral therapy (HAART) throughout pregnancy [1]. Women
who undergo primary HIV-1 infection during pregnancy,
however are at high risk of perinatal transmission [2].
Materials and methods
MTCT rates among patients receiving antenatal HAART at
our institution were evaluated and compared to MTCT
rates among women identified as HIV-1 infected late in
pregnancy including women who became HIV-1 seropos-
itive during gestation. Rapid HIV testing of pregnant
women was performed on all women admitted in labor to
our institution who had negative HIV results > 3 months
prior or with unknown HIV-1 serostatus. Neonatal infec-
tion was ascertained using RNA and DNA PCR at several
time points.
Results
Over two years, deliveries at our institution totalled
11,241 with 318 (2.9%) occurring in HIV-1 infected
women. The incidence of HIV-1 seroconversion was 0.8/
1,000 (CI 95% 0.4-1.5/1,000). The study population con-
sisted of 256 HIV+ women who delivered at our institu-
tion having received prenatal care at our hospital and
HAART during pregnancy or were identified as HIV-
infected at delivery. Of these, 212 women had infants
with known HIV outcomes. To 168 women on HAART,
142 infants (84%) had diagnosis ascertained: 1 child was
HIV-infected (0.6%). Of the remaining, 6 (3.6%) deaths
occurred in the neonatal period; 5 (3.0%) women miscar-
ried and 15 (8.9%) infants were lost to follow-up. Eighty-
eight women received no antiretroviral treatment being
identified as HIV-1 infected at delivery. Infant diagnosis
was ascertained in 70 cases. For the remainder, 4 (4.4%)
neonatal deaths occurred before diagnosis, 7 (8.0%)
women miscarried and 7 (8.0%) infants were lost to fol-
low-up. Of these, 61 had unknown HIV-1 seroconversion
time and 9 had proven seroconversion during pregnancy.
In women with no treatment and unknown seroconver-
sion time, there were 5/61 transmissions (8.2%) and in
those with proven seroconversion 3/9 (33%). No women
breastfed.
Conclusions
In southern Brazil, an area of high HIV-1 prevalence, sero-
conversion during pregnancy is not an unusual phenom-
enon and is associated with extremely high HIV-1 MTCT
rates. Strategies should be implemented for repeat testing
of patients later in pregnancy in addition to testing of
partners early in pregnancy in order to identify patients at
risk of seroconversion.
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